Damon Runyon identifies today’s most brilliant early career scientists and funds their innovative cancer research.
- Today’s Promising Areas of Cancer Research
- What is Cancer?
- A Broken Pipeline?
A Generation of Science at Risk
- ARISE Report
Early Career Scientists and High-Risk, High Reward Research - American Academy of Arts and Sciences
- Why We’re Losing the War on Cancer (And How To Win It)
Clifton Leaf - Fortune Magazine
December 28, 2009 > Tumor self-seeding described
Don X. Nguyen, PhD (Damon Runyon Fellow ‘05-‘08) and colleagues in the lab of Joan Massagué, PhD (Former Fellowship Award Committee), at Memorial Sloan-Kettering Cancer Center, New York, identified a new process termed “tumor self-seeding” by which aggressive circulating tumor cells (CTCs) return to recolonize their tumors of origin. The researchers found that self-seeding can accelerate tumor growth and angiogenesis through activation of cytokines IL-6 and IL-8, which attract the most aggressive CTCs back to the original tumor, and factors FSCN1 and MMP1, which mediate the physical infiltration of CTCs into a tumor. These findings may lead to new targeted therapies that interfere with the self-seeding process and thus slow or prevent tumor progression. This study was published in the journal Cell.



